0001178913-22-003139 | 6-K | XBRL Viewer

Document and Entity Information	6 Months Ended
Jun. 30, 2022
Cover Abstract
Entity Registrant Name	ALLOT LTD.
Entity Central Index Key	0001365767
Document Type	6-K
Document Period End Date	Jun. 30, 2022
Amendment Flag	false
Document Fiscal Year Focus	2022
Current Fiscal Year End Date	--12-31
Document Fiscal Period Focus	Q2
Entity Address, Address Line One	22 Hanagar Street
Entity Address, Address Line Two	Neve Ne'eman Industrial Zone B
Entity Address, City or Town	Hod-Hasharon
Entity Address, Postal Zip Code	45240
Entity Address, Country	IL

CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Income Statement [Abstract]
Revenues	$ 32,772	$ 35,288	$ 64,668	$ 66,471
Cost of revenues	10,242	10,822	20,034	20,413
Gross profit	22,530	24,466	44,634	46,058
Operating expenses:
Research and development costs, net	12,480	11,373	24,510	21,940
Sales and marketing	12,220	12,818	23,909	24,411
General and administrative	4,303	4,080	8,340	7,280
Total operating expenses	29,003	28,271	56,759	53,631
Operating loss	(6,473)	(3,805)	(12,125)	(7,573)
Financial and other income, net	620	194	867	309
Loss before income tax expenses	(5,853)	(3,611)	(11,258)	(7,264)
Tax expenses	380	368	1,102	673
Net Loss	$ (6,233)	$ (3,979)	$ (12,360)	$ (7,937)
Basic net loss per share	$ (0.17)	$ (0.11)	$ (0.34)	$ (0.22)
Diluted net loss per share	$ (0.17)	$ (0.11)	$ (0.34)	$ (0.22)
Weighted average number of shares used in computing basic net loss per share (shares)	36,827,197	35,941,378	36,684,017	35,739,556
Weighted average number of shares used in computing diluted net loss per share (shares)	36,827,197	35,941,378	36,684,017	35,739,556

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021
CURRENT ASSETS:
Cash and cash equivalents	$ 15,461	$ 11,717
Short-term bank deposits	85,900	60,720
Restricted deposits	1,100	1,480
Available-for-sale marketable securities	5,319	11,531
Trade receivables, net	36,288	30,829
Other receivables and prepaid expenses	8,629	8,490
Inventories	12,256	11,092
Total current assets	164,953	135,859
LONG-TERM ASSETS:
Long-term bank deposits	215	215
Severance pay fund	369	407
Operating lease right-of-use assets	7,134	8,513
Trade receivables, net	5,991	6,643
Other assets	1,203	1,639
Total long-term assets	14,912	17,417
PROPERTY AND EQUIPMENT, NET	14,809	15,000
GOODWILL AND INTANGIBLE ASSETS, NET	34,668	35,138
Total assets	229,342	203,414
CURRENT LIABILITIES:
Trade payables	3,003	3,940
Deferred revenues	26,765	22,138
Short-term operating lease liabilities	2,722	2,785
Other payables and accrued expenses	26,073	26,250
Total current liabilities	58,563	55,113
LONG-TERM LIABILITIES:
Deferred revenues	12,444	15,942
Long-term operating lease liabilities	3,588	5,467
Accrued severance pay	866	884
Convertible Debt	39,475	0
Total long-term liabilities	56,373	22,293
SHAREHOLDERS' EQUITY	114,406	126,008
Total liabilities and shareholders' equity	$ 229,342	$ 203,414

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Cash flows from operating activities:
Net loss	$ (6,233)	$ (3,979)	$ (12,360)	$ (7,937)
Adjustments to reconcile net income to net cash used in operating activities:
Depreciation	1,332	1,141	2,746	2,229
Stock-based compensation	2,169	2,261	4,706	3,705
Amortization of intangible assets	235	234	470	471
Increase (Decrease) in accrued severance pay, net	26	12	20	(60)
Decrease (increase) in other assets	19	(458)	436	1,041
Decrease in accrued interest and amortization of premium on marketable securities	16	32	48	107
Changes in operating leases, net	(191)	(479)	(563)	(711)
Increase in trade receivables	(4,082)	(3,113)	(4,807)	(10,256)
Decrease (Increase) in other receivables and prepaid expenses	141	3,094	(893)	3,522
Decrease (Increase) in inventories	591	4,246	(1,164)	3,289
Decrease in long-term deferred taxes, net	0	103	0	175
Increase (Decrease) in trade payables	(1,433)	334	(937)	(536)
Increase (decrease) in employees and payroll accruals	523	1,286	(1,963)	(623)
Increase in deferred revenues	287	1,640	1,129	16,612
Decrease in other payables, accrued expenses and other long term liabilities	(1,252)	(2,761)	(1,523)	(3,364)
Amortization of issuance costs of Convertible debt	49	0	71	0
Net cash provided by (used in) operating activities	(7,803)	3,593	(14,584)	7,664
Cash flows from investing activities:
Decrease (increase) in restricted deposit	260	(2,440)	380	(2,874)
Redemption of (Investment in) short-term deposits	520	100	(25,180)	(24,200)
Purchase of property and equipment	(1,281)	(1,934)	(2,556)	(3,629)
Proceeds from redemption or sale of available-for sale marketable securities	2,872	3,231	6,030	7,579
Net cash provided by (used in) investing activities	2,371	(1,043)	(21,326)	(23,124)
Cash flows from financing activities:
Proceeds from exercise of stock options	15	908	250	2,467
Issuance of convertible debt	0	0	39,404	0
Net cash provided by financing activities	15	908	39,654	2,467
Increase (Decrease) in cash and cash equivalents	(5,417)	3,458	3,744	(12,993)
Cash and cash equivalents at the beginning of the period	20,878	7,148	11,717	23,599
Cash and cash equivalents at the end of the period	$ 15,461	$ 10,606	$ 15,461	$ 10,606

Print Document View Excel Document
Cover Document and Entity Information Financial Statements CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS CONSOLIDATED BALANCE SHEETS CONSOLIDATED STATEMENTS OF CASH FLOWS All Reports